Diligence memo · auto-generated · as of July 2, 2026
OptimizeRx Corp
OptimizeRx Corp looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
OptimizeRx Corp operates in Other Health Care, based in ROCHESTER.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
OptimizeRx Corp has raised $26M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $10M on 2014-07-01.
Most recent recorded round closed around 2018-05-04.
Valuation (modeled)modeled
Provath models OptimizeRx Corp at approximately $182M (range $12M–$988M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.50× the median modeled value of Series A Other Health Care companies in 2016–2018 (157 peers) — value vs value, same stage and era. Within the normal band (150% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 39 months.
Last raise 8.2 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.1× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 87% of Other Health Care peers (5376 compared).
Modeled value ranks above 87% of those peers.
Closest niche peers: HemoSonics, LLC, Airxpanders Inc, Mercator Medsystems Inc, Simple Contacts Inc., AVG Holdings, Inc..
Peoplefiled
11 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.